cn128
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 15, 2018 (NCT03673085)
Timeline
Indications
Studied for
Mechanism of action
- IronCHELATING AGENT
Iron chelating agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05355766 | Phase 2 | Jun 2, 2022 | Hacettepe University, Hangzhou Zede Pharma-Tech Co., Ltd. |
| NCT04614779 | Phase 2 | Sep 30, 2020 | Hacettepe University, Hangzhou Zede Pharma-Tech Co., Ltd. |
| NCT03935633 | Phase 1 | Dec 3, 2018 | Hangzhou Zede Pharma-Tech Co., Ltd. |
| NCT03673085 | Phase 1 | Jan 15, 2018 | Hangzhou Zede Pharma-Tech Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hangzhou Zede Pharma-Tech Co., Ltd. | For profit | 4 | 4 | 2 | 2018 |
| Hacettepe University | Academic/Hospital | 2 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1